Construction begins at new centre of excellence for UCL Neuroscience

UCL President & Provost Dr Michael Spence was today joined by construction partner ISG and University College London Hospitals NHS Foundation Trust at a ceremony marking the start of construction of the new home of UCL Neuroscience. The landmark facility at 256 Grays Inn Road, London, will bring together research scientists, clinicians and patients to create a world-class research and treatment environment to tackle neurological diseases like dementia, which now count as the world's leading cause of disability. The state-of-the-art facilities will be home to three bodies: the world-leading UCL Queen Square Institute of Neurology; the headquarters of the UK Dementia Research Institute, which is the single biggest investment the UK has ever made in dementia; and the UCLH National Hospital for Neurology and Neurosurgery (NHNN), which is the UK's largest dedicated neurological and neurosurgical hospital. The NHNN, with a world leading reputation in care and treatment for people with neurological conditions, will have an outpatient and imaging service. Co-locating treatment with research will support the development of cutting-edge treatment geared towards patients' needs, enabling advances in clinical practice to happen with little delay. Clinical work and research will take place together within the new facility, enabling an active dialogue between people with neurological disorders, their doctors, and researchers.